Insulin shows why we need a public option in the pharma industry - STAT

Insulin shows why we need a public option in the pharma industry - STAT

Insulin: a case study for why we need a public option in the pharmaceutical industry

By DANA BROWN AND ELIZABETH PFIESTER

HULTON ARCHIVE/GETTY IMAGES

The high cost of insulin, which has led some with diabetes to ration this essential medicine, is a case study for why we need a public pharma industry.

READ MORE